AssetMark’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
AssetMark's RIGL Position: Q3 2026 in Review
AssetMark opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 1 share worth $48. The stake represents ﹤0.01% of the portfolio and ranks #3719 among its holdings.
127 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- AssetMark held 1 share of Rigel Pharmaceuticals worth $48 as of Q3 2026.
- Rigel Pharmaceuticals was a new AssetMark position in Q3 2026.
- Rigel Pharmaceuticals made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3719 holding.
- 127 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.